Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
BJU International
|
October 2, 2012
Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint
Peter Grimm, Ignace Billiet, David Bostwick
Virchows Archiv : an International Journal of Pathology
|
October 31, 2025
The consensus conference: pitfalls and problems
Brett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
Virchows Archiv : an International Journal of Pathology
|
June 5, 2026
Reply to Varma et al. regarding building consensus in medicine: issues and potential solutions
Brett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
The Journal of Urology
|
September 23, 2003
Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias
Filippos I Kondylis, Richard P Moriarty, David Bostwick, et al.
Journal of Oncology
|
September 18, 2010
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy
Michael Dattoli, Kent Wallner, Lawrence True, et al.
The Journal of Urology
|
November 11, 2005
The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge
Gerald Andriole, David Bostwick, Francisco Civantos, et al.
Journal of Chemical Ecology
|
April 6, 2006
Chemical defenses promote persistence of the aquatic plant Micranthemum umbrosum
John D Parker, Dwight O Collins, Julia Kubanek, et al.
The Journal of Urology
|
January 10, 2004
Comprehensive evaluation of ureteral healing after electrosurgical endopyelotomy in a porcine model: original report and review of the literature
Cassio R Andreoni, Hsueh-Kung Lin, Ephrem Olweny, et al.
The Journal of Urology
|
August 8, 2006
Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial
David Price, Barry Stein, Paul Sieber, et al.
The Journal of Urology
|
September 17, 2004
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial
Gerald Andriole, David Bostwick, Otis Brawley, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
BJU International
|
October 2, 2012
Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint
Peter Grimm, Ignace Billiet, David Bostwick
Virchows Archiv : an International Journal of Pathology
|
October 31, 2025
The consensus conference: pitfalls and problems
Brett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
Virchows Archiv : an International Journal of Pathology
|
June 5, 2026
Reply to Varma et al. regarding building consensus in medicine: issues and potential solutions
Brett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
The Journal of Urology
|
September 23, 2003
Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias
Filippos I Kondylis, Richard P Moriarty, David Bostwick, et al.
Journal of Oncology
|
September 18, 2010
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy
Michael Dattoli, Kent Wallner, Lawrence True, et al.
The Journal of Urology
|
November 11, 2005
The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge
Gerald Andriole, David Bostwick, Francisco Civantos, et al.
Journal of Chemical Ecology
|
April 6, 2006
Chemical defenses promote persistence of the aquatic plant Micranthemum umbrosum
John D Parker, Dwight O Collins, Julia Kubanek, et al.
The Journal of Urology
|
January 10, 2004
Comprehensive evaluation of ureteral healing after electrosurgical endopyelotomy in a porcine model: original report and review of the literature
Cassio R Andreoni, Hsueh-Kung Lin, Ephrem Olweny, et al.
The Journal of Urology
|
August 8, 2006
Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial
David Price, Barry Stein, Paul Sieber, et al.
The Journal of Urology
|
September 17, 2004
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial
Gerald Andriole, David Bostwick, Otis Brawley, et al.
Page
of 2